In vitro Differentiation of Melanocyte Stem Cells Derived from Vitiligo Patients into Functional Melanocytes
Abstract
BACKGROUND: Melanocyte stem cells (MelSCs) residing in the hair follicle bulge act as melanocyte reservoir for skin and hair, and may serve as an autologous source for treating vitiligo. Therefore, the study aimed to evaluate the in vitro differentiation ability of MelSCs derived from vitiligo patients into melanin-producing melanocytes for potential cellular therapy.
METHODS: MelSCs from the vitiliginous (V-MelSCs), non-vitiliginous (NV-MelSCs) regions of vitiligo patients, as well as from control subjects (C-MelSCs) were established for evaluating their differentiation potential into melanin producing cells. The differentiation abilities were compared at the cellular and molecular levels. MelSCs were differentiated in vitro into induced-melanocytes (iMCs) by supplementing the culture medium with melanogenic factors. iMCs were analyzed by quantitative polymerase chain reaction (qPCR) for the expression of key melanogenic markers, including tyrosinase (TYR), tyrosinase-related protein 1 (TYRP1), dopachrome tautomerase (DCT), microphthalmia-associated transcription factor (MITF), c-KIT and S100. iMCs were also stained with L-DOPA to assess TYR activity in cells. Intracellular melanin content in iMCs was evaluated and compared among the vitiligo and control groups.
RESULTS: MelSCs induced into iMCs displayed morphological changes with longer dendrites and prominent nuclei. iMCs stained positive for L-DOPA with an average intracellular melanin content of 30 pg/cell. iMCs expressed key melanogenic genes and the relative expression did not differ significantly among the groups.
CONCLUSION: NV-MelSCs were unaltered by disease pathogenesis and capable of differentiating into melanocytes compared to V-MelSCs. Hence, these cells might offer a reliable source of melanocytes for vitiligo repigmentation therapy by autologous cellular transplantation.
KEYWORDS: melanocyte stem cells, differentiation, melanocytes, vitiligo, in vitro
Full Text:
PDFReferences
Ashique KT, Jayasree P, Kaliyadan F. A multipurpose handle for vitiligo surgery and beyond. Indian J Dermatol Venereol Leprol. 2023; 89(6): 923-94, CrossRef.
Iwanowski T, Kołkowski K, Nowicki RJ, Sokołowska-Wojdyło M. Etiopathogenesis and emerging methods for treatment of vitiligo. Int J Mol Sci. 2023; 24(11): 9749, CrossRef.
Nilforoushzadeh MA, Ataei A, Zare S. Two methods with less donor site complications of epidermal cellular grafting in cell therapy of vitiligo. Iran J Public Health. 2023; 52(9): 2021-4, CrossRef.
Chen PH, Mai-Yi Fan S, She BR, Wu YP, Hsu HC, Yang YJ, et al. Melanocyte transplantation to skin prepared by controlled PUVA-induced sunburn-like blistering for vitiligo treatment - A pilot clinical trial. J Formos Med Assoc. 2023; 2023: S0929-6646(23)00485-0, CrossRef.
Souroujon AA, Guttman I, Levin N, Capuano G, Reyes Salcedo CA, García P. Autologous cell transplant as a treatment for stable segmental vitiligo: A systematic review. Int J Dermatol. 2023; 62(11): 1324-31, CrossRef.
Uitentuis SE, Lommerts JE, Willemsen M, Willemsen K, de Rie MA, Luiten RM, et al. Addition of cell suspension transplantation to UVB and topical treatment in non-segmental vitiligo: A randomized controlled study. Int J Dermatol. 2024; 63(1): e4-6, CrossRef.
Gho CG, Braun JE, Tilli CM, Neumann HA, Ramaekers FC. Human follicular stem cells: Their presence in plucked hair and follicular cell culture. Br J Dermatol. 2004; 150(5): 860-8, CrossRef.
Meilana A, Dewi NM, Wijaya A. Heterogeneous stem cells in skin homeostatis and wound repair. Indones Biomed J. 2015; 7(2): 87-100, CrossRef.
Meyer KC, Klatte JE, Dinh HV, Harries MJ, Reithmayer K, Meyer W, et al. Evidence that the bulge region is a site of relative immune privilege in human hair follicles. Br J Dermatol. 2008; 159(5): 1077-85, CrossRef.
Yamada T, Hasegawa S, Inoue Y, Date Y, Yamamoto N, Mizutani H, et al. Wnt/β-catenin and kit signaling sequentially regulate melanocyte stem cell differentiation in UVB-induced epidermal pigmentation. J Invest Dermatol. 2013; 133(12): 2753-62, CrossRef.
Meiliana A, Dewi NM, Wijaya A. Stem cell therapy in wound healing and tissue regeneration. Indones Biomed J. 2016; 8(2): 61-70, CrossRef.
Manchi V, Shetty S, Shetty N, Rao S, Shetty V, Yeshwanth SK, et al. Establishment and characterization of melanocyte stem cells from hair follicle bulge of vitiligo patients. J Appl Biotechnol Reports. 2023; 10(3): 1069-78, article.
Lee JH, Choi S. Deciphering the molecular mechanisms of stem cell dynamics in hair follicle regeneration. Exp Mol Med. 2024; 56(1): 110-7, CrossRef.
Jara JR, Solano F, Lozano JA. Assays for mammalian tyrosinase: A comparative study. Pigment Cell Res. 1988; 1(5): 332-9, CrossRef.
Slominski A, Moellmann G, Kuklinska E, Bomirski A, Pawelek J. Positive regulation of melanin pigmentation by two key substrates of the melanogenic pathway, L-tyrosine and L-dopa. J Cell Sci. 1988; 89(PART III): 287-96, CrossRef.
D’Mello SAN, Finlay GJ, Baguley BC, Askarian-Amiri ME. Signaling pathways in melanogenesis. Int J Mol Sci. 2016; 17(7): 1144, CrossRef.
Reid K, Turnley A, Maxwell G, Kurihara Y, Kurihara H, Barlett P, et al. Multiple roles for endothelin in melanocyte development: regulation of progenitor number and stimulation of differentiation. Development. 1996; 122(12): 3911-9, CrossRef.
Hirobe T. Endothelins are involved in regulating the proliferation and differentiation of mouse epidermal melanocytes in serum-free primary culture. J Investig Dermatology Symp Proc. 2001; 6(1): 25-31, CrossRef.
Tang J, Li Q, Cheng B, Jing L. Primary culture of human face skin melanocytes for the study of hyperpigmentation. Cytotechnology. 2014; 66(6): 891-8, CrossRef.
Sturm RA, O'Sullivan BJ, Box NF, Smith AG, Smit SE, Puttick ER, et al. Chromosomal structure of the human TYRP1 and TYRP2 loci and comparison of the tyrosinase-related protein gene family. Genomics. 1995; 29(1): 24-34, CrossRef.
Olivares C, Jiménez-Cervantes C, Lozano JA, Solano F, García-Borrón JC. The 5,6-dihydroxyindole-2-carboxylic acid (DHICA) oxidase activity of human tyrosinase. Biochem J. 2001; 354(Pt 1): 131-9, CrossRef.
Steel KP, Davidson DR, Jackson IJ. TRP-2/DT, a new early melanoblast marker, shows that steel growth factor (c-kit ligand) is a survival factor. Development. 1992; 115(4): 1111-9, CrossRef.
Lang D, Mascarenhas JB, Shea CR. Melanocytes, melanocyte stem cells, and melanoma stem cells. Clin Dermatol. 2013; 31(2): 166-78, CrossRef.
Qiu W, Yang K, Lei M, Yan H, Tang H, Bai X, et al. SCF/c-kit signaling is required in 12-O-tetradecanoylphorbol-13-acetate-induced migration and differentiation of hair follicle melanocytes for epidermal pigmentation. Cell Tissue Res. 2015; 360(2): 333-46, CrossRef.
Gleason BC, Crum CP, Murphy GF. Expression patterns of MITF during human cutaneous embryogenesis: Evidence for bulge epithelial expression and persistence of dermal melanoblasts. J Cutan Pathol. 2008; 35(7): 615-22, CrossRef.
Gelmi MC, Houtzagers LE, Strub T, Krossa I, Jager MJ. MITF in normal melanocytes, cutaneous and uveal melanoma: A delicate balance. Int J Mol Sci. 2022; 23(11): 6001, CrossRef.
Widlund HR, Fisher DE. Microphthalamia-associated transcription factor: A critical regulator of pigment cell development and survival. Oncogene. 2003; 22(20): 3035-41, CrossRef.
Ali IQ, Salih SM, Abdulla GA. Differentiation of CD34+ human hair follicle stem cells into functional melanocytes. IOP Conf Ser Mater Sci Eng. 2018; 454(1): 012013, CrossRef.
Kumari U, Pervaiz N, Kaur H, Sharma H, Parsad D, Kumar R. Lenalidomide augments differentiation of cultured hair follicle derived melanocyte stem cells into functional melanocytes. Dermatol Pract Concept. 2023; 13(2): e2023077, CrossRef.
DOI: https://doi.org/10.18585/inabj.v16i2.2942
Copyright (c) 2024 The Prodia Education and Research Institute
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Indexed by:
The Prodia Education and Research Institute
